Could Molnupiravir Be the First-Line Alternative Oral Antiviral Agent for COVID-19 Patients at High Risk? | J Korean Med Sci;39(6): e74, 2024 Feb 19. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Could Molnupiravir Be the First-Line Alternative Oral Antiviral Agent for COVID-19 Patients at High Risk?

Lee, Ji Yong.

Affiliation

Lee JY; Division of Infectious Disease, Department of Internal Medicine, Gumdan Top Hospital, Incheon, Korea. godjong454@naver.com.

J Korean Med Sci ; 39(6): e74, 2024 Feb 19.

Article in En | MEDLINE | ID: mdl-38374633

Subject(s)

COVID-19; Cytidine/analogs & derivatives; Humans; Hydroxylamines; Antiviral Agents/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytidine / COVID-19 Limits: Humans Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2024 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytidine / COVID-19 Limits: Humans Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2024 Document type: Article